Medtronic to boost ai innovation with new platform introduction

A strategic collaboration with cosmo pharmaceuticals   and nvidia delivers the gi genius™ ai access™ platform designed to accelerate ai innovation for healthcare. dublin , march 22, 2023 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, today announced cosmo pharmaceuticals  and nvidia plan to integrate nvidia's ai technologies into the gi genius™ intelligent endoscopy module — the first fda-cleared, ai-assisted colonoscopy tool to help physicians detect polyps that can lead to colorectal cancer.
MDT Ratings Summary
MDT Quant Ranking